The development of Ecchymosis after administration of convalescent Serum in a Patient with COVID-19 Associated with Thrombocytosis

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

COVID-19 can have an unpredictable and severe course, leading to many hypotheses regarding its pathophysiology and clinical manifestations. Haematological manifestations are a significant predictor of disease severity. The most common observation is lymphopenia with an increased neutrophil:lymphocyte ratio. Platelets have been implicated in thrombogenic events, but the most frequently reported abnormality is mild thrombocytopenia. Here we present an interesting case of a patient with moderate COVID-19 who presented with cutaneous ecchymoses and thrombocytosis, and discuss this paradox.

Cite

CITATION STYLE

APA

Khot, R., Kumbhalkar, S. D., Juneja, R., & Joshi, P. P. (2021). The development of Ecchymosis after administration of convalescent Serum in a Patient with COVID-19 Associated with Thrombocytosis. European Journal of Case Reports in Internal Medicine, 8(9). https://doi.org/10.12890/2021_002782

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free